Marinus Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BERYL CAPITAL MANAGEMENT LLC | 02/14/2025 | 4.23 M | $2.26 M | 100.00% | 7.39% |
| MORGAN STANLEY | 02/14/2025 | 3.30 M | $1.77 M | 1,898.71% | 5.76% |
| 02/12/2025 | 2.70 M | $1.44 M | 100.00% | 4.72% | |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 2.69 M | $1.44 M | 0.00% | 4.71% |
| ABRDN PLC | 01/24/2025 | 2.66 M | $1.42 M | 0.00% | 4.65% |
| VANGUARD GROUP INC | 02/11/2025 | 2.60 M | $1.39 M | -7.36% | 4.54% |
| WOODLINE PARTNERS LP | 02/14/2025 | 2.34 M | $1.25 M | 84.75% | 4.08% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 1.84 M | $983,000 | 80.74% | 3.21% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.64 M | $878,605 | -65.07% | 2.87% |
| BLACKROCK, INC. | 02/07/2025 | 883,675 | $472,854 | -52.47% | 1.54% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 696,740 | $371,000 | -23.46% | 1.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 529,053 | $283,210 | -6.94% | 0.92% |
| CITADEL ADVISORS LLC | 02/14/2025 | 501,911 | $268,573 | 108.78% | 0.88% |
| JPMORGAN CHASE & CO | 02/12/2025 | 487,584 | $260,906 | 266.08% | 0.85% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 363,800 | $196,452 | 280.94% | 0.64% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 290,000 | $152,569 | 0.00% | 0.51% |
| UBS GROUP AG | 02/14/2025 | 258,944 | $138,535 | 11,367.85% | 0.45% |
| ROYAL BANK OF CANADA | 02/14/2025 | 249,138 | $134,000 | 303.42% | 0.44% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 239,414 | $128,110 | -50.38% | 0.42% |
| STATE STREET CORP | 02/14/2025 | 222,576 | $119,100 | 7.80% | 0.39% |
| XTX TOPCO LTD | 02/13/2025 | 219,819 | $117,625 | 1,564.66% | 0.38% |
| DELTEC ASSET MANAGEMENT LLC | 01/27/2025 | 200,000 | $107,020 | 100.00% | 0.35% |
| NORTHERN TRUST CORP | 02/14/2025 | 113,280 | $60,616 | -3.89% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 100,853 | $53,966 | 36.51% | 0.18% |
| GABELLI & CO INVESTMENT ADVISERS, INC. | 02/13/2025 | 100,000 | $53,510 | 100.00% | 0.17% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 66,717 | $36,000 | 100.00% | 0.12% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 57,128 | $30,569 | -87.14% | 0.10% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 52,328 | $28,001 | 30.57% | 0.09% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 44,200 | $24,000 | 0.00% | 0.08% |
| HARVEST INVESTMENT SERVICES, LLC | 02/14/2025 | 41,144 | $22,016 | 100.00% | 0.07% |
| HRT FINANCIAL LP | 02/14/2025 | 30,943 | $16,000 | 100.00% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 23,199 | $12,411 | 68.54% | 0.04% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 22,868 | $12,237 | -52.02% | 0.04% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 20,779 | $11,119 | 7.79% | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 20,356 | $10,893 | -95.09% | 0.04% |
| CITADEL ADVISORS LLC | 02/14/2025 | 16,900 | $9,043 | 32.03% | 0.03% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 16,023 | $8,574 | -45.65% | 0.03% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 12,897 | $6,901 | -61.66% | 0.02% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 12,518 | $7,000 | -0.79% | 0.02% |
| PERFROMANCE WEALTH PARTNERS, LLC | 01/17/2025 | 11,000 | $5,886 | 0.00% | 0.02% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 9,526 | $5,000 | -82.24% | 0.02% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 6,310 | $3,376 | -46.04% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 5,724 | $10,074 | -47.97% | 0.01% |
| COPPELL ADVISORY SOLUTIONS LLC | 02/14/2025 | 3,092 | $31,415 | 0.00% | 0.01% |
| FEDERATED HERMES, INC. | 02/13/2025 | 2,286 | $1,223 | -38.88% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2025 | 1,900 | $1,017 | -94.49% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 1,800 | $963 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 1,653 | $885 | -99.40% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 1,322 | $707 | 100.00% | 0.00% |
| 1620 INVESTMENT ADVISORS, INC. | 02/11/2025 | 1,000 | $535 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Marinus Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 85 institutional investors and hedge funds held shares of Marinus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Assenagon Asset Management S.A.: 0
FIFTH THIRD BANCORP: 0
Perfromance Wealth Partners, LLC: 0
DELTEC ASSET MANAGEMENT LLC: 0
Beryl Capital Management LLC: 4.23 M
MORGAN STANLEY: 3.3 M
51.63% of Marinus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.73 M shares in the last 24 months. This purchase volume represents approximately $0 in transactions.